Lincoln Pharmaceuticals Limited — Board Meeting, 28-05-2026: Outcome of Board Meeting
28-05-2026 | 05:09 pm
28-05-2026 | 05:09 pm
Lincoln Pharma reports FY26 consolidated net profit of Rs 87.89 Cr (up 6.74%) and revenue of Rs 704.48 Cr (up 9.10%). The board proposed a final dividend of ₹1.80/share for FY26. Company targets Rs 1,000 Cr revenue in 3 years.
No comments yet. Be the first to comment!
